AI-based Prediction of Prostate Cancer Metastasis Using Biopsy Pathology

This observational study aims to develop and validate an artificial intelligence-based model using prostate cancer biopsy pathology to predict lymph node metastasis and distant metastasis in patients with prostate cancer. The main questions it aims to answer are: Can artificial intelligence-assisted analysis of prostate cancer biopsy pathology accurately predict lymph node metastasis? Can the model accurately predict distant metastasis and assess metastatic risk in patients with prostate cancer? Researchers aim to evaluate whether the model can provide additional information for clinical decision-making and surgical planning. Participants will: Provide prostate biopsy pathology specimens and related clinical information; Undergo assessment of lymph node and distant metastatic status based on clinical and imaging data; Be included in the development and validation of the artificial intelligence prediction model.

NCT Number	NCT07660276
Lead Sponsor	Xiangya Hospital of Central South University
Conditions	Prostate Cancer Metastatic
Enrollment	3,000 participants
Start Date	2026-01-08
Primary Completion	2026-08-01 (estimated)
Study Completion	2026-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-22